Ustekinumab Injection, Solution
Product Images NDC 57894-441

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Ustekinumab (NDC 57894-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ustekinumab 01)

An instructional diagram of a subcutaneous injection device for ustekinumab, showing labeled parts including the plunger, plunger head, needle guard activation clips, needle guard wings, body, viewing window with expiration date, label, needle, and needle cover.*

FDA Label Image

Image (Ustekinumab 02)

An instructional illustration showing a close-up of hands preparing a prefilled syringe of ustekinumab injection, solution. The image depicts the process of removing or adjusting the needle cap or safety device on the syringe prior to subcutaneous administration.*

FDA Label Image

Image (Ustekinumab 03)

An instructional illustration showing a hand holding a prefilled syringe, indicating the proper grip and usage technique. The syringe appears to be prepared for subcutaneous injection, consistent with injection solution products like ustekinumab.*

FDA Label Image

Figure 1 (Ustekinumab 04)

A line graph showing the percentage of patients over a 24-week period comparing placebo with ustekinumab doses of 45 mg and 90 mg. The x-axis represents weeks, and the y-axis indicates the percentage of patients. Three lines correspond to placebo, ustekinumab 45 mg, and ustekinumab 90 mg, illustrating patient response trends over time.*

FDA Label Image

Figure A (Ustekinumab 05)

An instructional illustration showing components for subcutaneous injection of ustekinumab. From left to right: an adhesive bandage, antiseptic wipes, a cotton ball or gauze pad, an ustekinumab prefilled syringe, and an FDA-cleared sharps disposal container. This diagram depicts preparation and injection materials for administering ustekinumab injection solution.*

FDA Label Image

Figure B (Ustekinumab 06)

An instructional diagram of a subcutaneous injection device for ustekinumab injection solution. The labeled parts include the plunger, plunger head, needle guard activation clips, needle guard wings, body, viewing window, label (showing an expiration date), needle, and removable needle cover.*

FDA Label Image

Figure C (Ustekinumab 07)

Illustration showing recommended subcutaneous injection sites for ustekinumab injection solution. Highlighted areas on a human figure include the upper arm, thigh, abdomen (except around the navel), and buttocks from a rear view.*

FDA Label Image

Figure D (Ustekinumab 08)

An instructional illustration showing two hands preparing a syringe injection. One hand holds the syringe with the needle cover still attached, while the other hand holds the needle cap with arrows indicating the removal direction of the needle cap.*

FDA Label Image

Figure E (Ustekinumab 09)

An instructional illustration showing a hand holding a prefilled syringe for subcutaneous injection. The syringe is positioned with the needle pointing downward, indicating the preparation or administration step for ustekinumab injection, solution.*

FDA Label Image

Figure F (Ustekinumab 10)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe at a 45-degree angle into the skin of a person's abdomen or thigh. The diagram emphasizes proper needle angle for injection technique.*

FDA Label Image

Figure G (Ustekinumab 11)

Illustration showing a close-up of a hand holding an injection device labeled with a date and a 0.5 mL volume, highlighting the needle guard wings on the device. This diagram demonstrates part of the handling or usage of a subcutaneous injection device.*

FDA Label Image

Figure H (Ustekinumab 12)

An instructional diagram showing a hand holding a prefilled syringe for subcutaneous injection. The image depicts the process of pulling back or adjusting the syringe plunger, indicated by an arrow guiding finger movement for handling the injection device.*

FDA Label Image

Figure A (Ustekinumab 13)

An instructional diagram showing components for ustekinumab subcutaneous injection preparation. It depicts an adhesive bandage, antiseptic wipes, a cotton ball or gauze pads, an ustekinumab vial, and a syringe with attached needle in sequence.*

FDA Label Image

Figure B (Ustekinumab 14)

Illustration showing recommended subcutaneous injection sites for ustekinumab injection, solution. Highlighted areas include the thigh, upper arm, abdomen, and buttocks as suitable locations for administering the injection.*

FDA Label Image

Figure C (Ustekinumab 15)

An instructional illustration showing a vial of solution with its rubber stopper being covered or uncovered by a flip-off cap. The vial is likely intended for subcutaneous injection, consistent with ustekinumab injection packaging.*

FDA Label Image

Figure D (Ustekinumab 16)

An instructional line drawing showing two hands removing a cap from a small vial or bottle, likely depicting preparation steps for an injection solution of ustekinumab.*

FDA Label Image

Figure E (Ustekinumab 17)

An instructional illustration showing two hands demonstrating the removal of a needle cap from a syringe. One hand holds the syringe, and the other pulls the cap straight off, indicated by arrows pointing in opposite directions.*

FDA Label Image

Figure F (Ustekinumab 18)

An instructional line drawing showing two hands preparing an injection. One hand holds a vial upright while the other hand inserts a syringe needle into the vial's rubber stopper, drawing liquid into the syringe. This image is related to the preparation of ustekinumab injection solution for subcutaneous use.*

FDA Label Image

Figure G (Ustekinumab 19)

An instructional line drawing showing two hands preparing a syringe by drawing liquid from a vial, demonstrating part of the injection preparation process for a subcutaneous injection.*

FDA Label Image

Figure H (Ustekinumab 20)

An instructional diagram showing two hands; one holds an inverted vial and the other holds a syringe filling it with the injection solution. This likely demonstrates the preparation of ustekinumab injection, solution, subcutaneous dosage form prior to administration.*

FDA Label Image

Figure I (Ustekinumab 21)

Illustration showing a hand administering a subcutaneous injection at a 45-degree angle into the skin of a person's thigh. The image demonstrates proper needle positioning for injection.*

FDA Label Image

Figure J (Ustekinumab 22)

An instructional illustration showing a hand holding a syringe for subcutaneous injection. The syringe is positioned with the needle pointing downward toward the skin, indicating the administration technique for an injection.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Vial Carton)

Packaging label for Ustekinumab Injection 45 mg/0.5 mL for subcutaneous use. The label includes storage instructions, ingredient details with no preservatives, manufacturer information (Janssen Biotech, Inc.), and administrative notes such as 'Rx only' and dispensing guidance. The label features a white and turquoise gradient background with purple text, barcodes, and the Janssen logo.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Syringe Carton)

Packaging label for Ustekinumab injection, 45 mg/0.5 mL subcutaneous solution. The carton indicates a single-dose prefilled syringe containing 45 mg ustekinumab per 0.5 mL, with additional inactive ingredients listed. The labeler is Janssen Biotech, Inc., and it includes directions to dispense the medication guide with each patient package.*

FDA Label Image

Principal Display Panel (90 mg/mL Syringe Carton)

Packaging label for Ustekinumab Injection 90 mg/mL, a single-dose prefilled syringe for subcutaneous use. The label specifies contents including ustekinumab and inactive ingredients, with usage instructions for dispensing the medication guide. Manufactured by Janssen Biotech, Inc.*

FDA Label Image

Principal Display Panel (130 mg/26 mL Vial Box)

Packaging label for Ustekinumab Injection 130 mg/26 mL (5 mg/mL) solution for intravenous infusion. The label states the product must be diluted before use and includes storage instructions to keep refrigerated at 2 °C to 8 °C in its original carton. Manufactured by Janssen Biotech, Inc. and labeled for U.S. distribution, it features dosage and handling warnings, ingredients, and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.